0.6723
price down icon9.01%   -0.0666
pre-market  プレマーケット:  .68   0.0077   +1.15%
loading
前日終値:
$0.7389
開ける:
$0.7499
24時間の取引高:
5.65M
Relative Volume:
1.02
時価総額:
$202.84M
収益:
$52.29M
当期純損益:
$-134.84M
株価収益率:
-0.8964
EPS:
-0.75
ネットキャッシュフロー:
$-117.11M
1週間 パフォーマンス:
-1.55%
1か月 パフォーマンス:
+26.42%
6か月 パフォーマンス:
-7.12%
1年 パフォーマンス:
-18.57%
1日の値動き範囲:
Value
$0.67
$0.7499
1週間の範囲:
Value
$0.652
$0.7646
52週間の値動き範囲:
Value
$0.4111
$3.179

Sangamo Therapeutics Inc Stock (SGMO) Company Profile

Name
名前
Sangamo Therapeutics Inc
Name
セクター
Healthcare (1140)
Name
電話
(510) 970-6000
Name
住所
501 CANAL BLVD., RICHMOND, CA
Name
職員
183
Name
Twitter
@sangamotx
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
SGMO's Discussions on Twitter

SGMO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SGMO
Sangamo Therapeutics Inc
0.6723 222.93M 52.29M -134.84M -117.11M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 アップグレード Truist Hold → Buy
2024-12-10 繰り返されました H.C. Wainwright Buy
2023-11-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-04-28 ダウングレード BofA Securities Neutral → Underperform
2023-02-27 アップグレード Wedbush Neutral → Outperform
2023-01-06 ダウングレード BofA Securities Buy → Neutral
2022-06-13 再開されました Wedbush Neutral
2021-05-04 開始されました RBC Capital Mkts Outperform
2021-01-07 再開されました Guggenheim Neutral
2021-01-06 開始されました Stifel Hold
2020-12-16 再開されました H.C. Wainwright Buy
2020-09-08 開始されました BofA Securities Buy
2020-07-07 開始されました SunTrust Buy
2019-08-26 開始されました H.C. Wainwright Buy
2018-11-14 ダウングレード JP Morgan Overweight → Neutral
2018-11-09 ダウングレード Guggenheim Buy → Neutral
2018-10-10 開始されました Guggenheim Buy
2018-06-20 開始されました BofA/Merrill Buy
2017-11-15 アップグレード Piper Jaffray Neutral → Overweight
2017-06-22 再開されました Jefferies Buy
2016-11-01 ダウングレード Wedbush Outperform → Neutral
2016-10-19 ダウングレード Piper Jaffray Overweight → Neutral
2015-12-04 開始されました Wells Fargo Outperform
2015-10-23 再開されました Jefferies Buy
2013-05-03 開始されました BioLogic Equity Research Sell
2011-02-23 繰り返されました JMP Securities Mkt Outperform
2010-07-29 繰り返されました Wedbush Outperform
2009-10-19 開始されました Brean Murray Sell
2009-10-07 繰り返されました Leerink Swann Outperform
2009-08-25 繰り返されました JMP Securities Mkt Outperform
すべてを表示

Sangamo Therapeutics Inc (SGMO) 最新ニュース

pulisher
02:57 AM

How Sangamo Therapeutics Inc. stock reacts to bond yields2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com

02:57 AM
pulisher
01:36 AM

Combining price and volume data for Sangamo Therapeutics Inc.Long Setup & Fast Gain Swing Trade Alerts - newser.com

01:36 AM
pulisher
01:21 AM

Combining machine learning predictions for Sangamo Therapeutics Inc.Earnings Miss & Technical Entry and Exit Alerts - newser.com

01:21 AM
pulisher
12:48 PM

What machine learning models say about Sangamo Therapeutics Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - newser.com

12:48 PM
pulisher
12:29 PM

Published on: 2025-10-12 23:29:27 - newser.com

12:29 PM
pulisher
Oct 10, 2025

Is Sangamo Therapeutics Inc. (GBY) stock a fit for income portfolios2025 Short Interest & Accurate Buy Signal Notifications - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will earnings trigger a reversal in Sangamo Therapeutics Inc.Entry Point & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Sangamo Therapeutics (NASDAQ:SGMO) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Volume spikes in Sangamo Therapeutics Inc. stock – what they meanWeekly Investment Summary & Community Consensus Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What analysts say about Sangamo Therapeutics Inc stockAnalyst Upgrades & Compound Your Gains With Quality Stocks - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

There's No Escaping Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Muted Revenues Despite A 28% Share Price Rise - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

Visual trend scoring systems applied to Sangamo Therapeutics Inc.Weekly Profit Summary & Step-by-Step Swing Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 03:38:37 - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Sangamo Therapeutics Inc. (GBY) stock stays on buy listsEarnings Miss & Weekly Breakout Stock Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Sangamo Therapeutics Inc. (GBY) stock a good hedge against inflationWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:08:49 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What hedge fund activity signals for Sangamo Therapeutics Inc. stock2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 02:36:48 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 07:10:00 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to monitor Sangamo Therapeutics Inc. with trend dashboards2025 Performance Recap & Fast Entry High Yield Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Why Sangamo Therapeutics Inc. (GBY) stock stays resilientEarnings Miss & Expert Verified Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Sangamo Biosciences CFO Resigns, New Officer Appointed - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

BRIEF-Sangamo Therapeutics Appoints Nikunj Jain As Principal Accounting Officer – SEC Filing - NewsX

Sep 30, 2025
pulisher
Sep 30, 2025

Sangamo Therapeutics appoints Nikunj Jain as principal accounting officerSEC filing - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

Sangamo Therapeutics, Inc. Appoints Nikunj Jain as Principal Accounting Officer, Effective October 1, 2025 - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Price Is Right But Growth Is Lacking After Shares Rocket 28% - 富途牛牛

Sep 30, 2025
pulisher
Sep 29, 2025

What analysts say about Tomra Systems ASA TMRA stockStochastic Oscillator Alerts & Target Triple-Digit Stock Opportunities - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 00:48:43 - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 22:48:05 - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Can Olympia Industries Limited Maintain Its Share of Global Market for Its ProductBollinger Bands Signals & Exceptional Capital Growth - earlytimes.in

Sep 28, 2025
pulisher
Sep 25, 2025

Goldman Sachs Group Inc. Sells 651,670 Shares of Sangamo Therapeutics, Inc. $SGMO - MarketBeat

Sep 25, 2025
pulisher
Sep 24, 2025

The Escalator: Zealand Pharma, Area 23, Sangamo Therapeutics and more - Medical Marketing and Media

Sep 24, 2025
pulisher
Sep 23, 2025

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Are In A Position To Invest In Growth - simplywall.st

Sep 23, 2025

Sangamo Therapeutics Inc (SGMO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
大文字化:     |  ボリューム (24 時間):